Font Size

SCREEN

Profile

Direction

Menu Style

In Brief
  1. ISIRV Journal: IRV Journal impact factor is now 4.4
  2. Abstract submission deadline for RSV2025 has been extended to 15 November.
13th International RSV Symposium (RSV2025)

Lance Jennings, Clinical Virologist, Canterbury Health Laboratories (retired) and
Associate Professor, Pathology Department, University of Otago, New Zealand

ISIRV Past-Chair (2013-2019)

Lance Jennings  QSO, PhD, FRCPath, FFSc(RCPA) -  Clinical Virologist to the Canterbury District Health Board, Director of New Zealand’s WHO National Measles Laboratory, Clinical Associate Professor in the Pathology Department, University of Otago, New Zealand, Fellow of the Royal College of Pathologists, London, and a Founding Fellow of the Science Faculty, Royal Australasian College of Pathologists.

He has been instrumental in the development of influenza control strategies for New Zealand, including the introduction of free influenza vaccine, establishment of influenza awareness education (NISG) and pandemic planning. His research interests focus on the epidemiology, diagnosis, treatment and prevention of influenza and other respiratory virus infections. He co-founded in 2002 the Asia Pacific Alliance for the Control of Influenza (APACI), a Charitable Trust, and is a Director and the immediate past-Chair. He was the Chair of ISIRV for the period 2013 - 2019 and is currently chairing the ISIRV Governance Committee.

Dr Jennings has been a member of WHO/WPRO Avian Influenza Outbreak Response and Expert Influenza teams in Asia and has held WHO short-term consultancies on measles and influenza in Asia and Europe. He serves on several Ministry of Health and PHARMAC technical advisory groups, and is on the editorial board of the International Society for Influenza and other Respiratory Virus Disease (ISIRV) journal Influenza and other Respiratory Viruses. In 2006 he was appointed as a Companion of the Queen’s Service Order in recognition of his service to virology in New Zealand and internationally.